Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner
Robert M Taylor,1,2 Laurel O Sillerud1,31Department of Biochemistry and Molecular Biology, 2New Mexico Cancer Nanoscience and Microsystems Training Center, 3UNM Cancer Center, University of New Mexico, Albuquerque, NM, USABackground and methods: Problems with the clinical management of prostate canc...
Guardado en:
Autores principales: | Taylor RM, Sillerud LO |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/45e5081921bd476e9ea08803c812a28b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Quantitative [Fe]MRI of PSMA-targeted SPIONs specifically discriminates among prostate tumor cell types based on their PSMA expression levels
por: Sillerud LO
Publicado: (2016) -
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI
por: Wei Liu, et al.
Publicado: (2022) -
Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA
por: Yu Wang, et al.
Publicado: (2021) -
Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
por: Kristin A. Plichta, et al.
Publicado: (2021) -
Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancer
por: Sarah Piron, et al.
Publicado: (2021)